[m6A methylase WTAP participates in renal ischemia-reperfusion injury by regulating FOXO1 expression]

G Zhao1, H Li1, H Zhang1

  • 1Department of Urology, First Affiliated Hospital of Xi'an Medical University, Xi'an 710000, China.

Abstract

Insights

WTAP expression increases in renal ischemia-reperfusion injury. Inhibiting WTAP reduces kidney cell damage and apoptosis by affecting FOXO1 expression, offering a potential therapeutic target for kidney injury.

Area of Science:

  • Molecular Biology
  • Renal Pathophysiology
  • Epithelial Cell Biology

Context:

  • Renal ischemia-reperfusion (I/R) injury is a significant cause of acute kidney injury.
  • The role of RNA methylation, specifically N6-methyladenosine (m6A), in I/R injury is an emerging area of research.
  • WTAP is a key component of the m6A methyltransferase complex.

Purpose:

  • To investigate the expression of WTAP in a mouse model of renal I/R injury.
  • To determine the effect of WTAP knockdown on renal tubular epithelial cells under hypoxia-reoxygenation (H/R) conditions.
  • To explore the potential mechanism involving FOXO1 in WTAP-mediated cellular responses.

Summary:

  • WTAP expression was significantly upregulated in the kidneys of mice subjected to I/R injury and in human renal tubular epithelial cells (HK-2) exposed to H/R.
  • Knockdown of WTAP in HK-2 cells attenuated H/R-induced cell damage, reduced apoptosis, and decreased cell viability.
  • WTAP was found to bind to FOXO1 mRNA, and its inhibition led to reduced m6A modification of FOXO1, suggesting a regulatory role in FOXO1 expression.

Impact:

  • This study identifies WTAP as a key mediator in renal I/R injury.
  • The findings suggest that targeting WTAP and its downstream effects on FOXO1 may offer a novel therapeutic strategy for mitigating kidney injury.
  • Provides mechanistic insights into the role of RNA m6A modification in the cellular response to ischemic stress.